Table 2.
Significantly different characteristics between patients with and without anemia or MBD
| Characteristics | All patients (n = 311) | All patients (n = 311) | ||
|---|---|---|---|---|
| Without anemia (n = 186) |
With anemia (n = 125) |
Without MBD (n = 166) |
With MBD (n = 145) |
|
| Gender, N (%) | ||||
| Female | 57 (30.7) | 73 (58.4)*** | 63 (38.0) | 67 (46.2) |
| Male | 129 (69.4) | 52 (41.6) | 103 (62.1) | 78 (53.8) |
| Education level, N (%) | ||||
| No education | 29 (15.6) | 35 (28.2)** | 35 (21.2) | 29 (20.0) |
| Primary | 55 (29.6) | 44 (35.5) | 45 (27.3) | 54 (37.2) |
| Secondary | 60 (32.3) | 27 (21.8) | 51 (30.9) | 36 (24.8) |
| Tertiary | 42 (22.6) | 18 (14.5) | 34 (20.6) | 26 (17.9) |
| Monthly income level, N (%) | ||||
| No income | 105 (56.8) | 93 (75.0)** | 100 (60.6) | 98 (68.1) |
| < $2000 | 42 (22.7) | 23 (18.6) | 33 (20.0) | 32 (22.2) |
| $2000–$3999 | 24 (13.0) | 5 (4.0) | 20 (12.12) | 9 (6.3) |
| $4000–$5999 | 8 (4.3) | 2 (1.6) | 8 (4.9) | 2 (1.4) |
| $6000–$9999 | 6 (3.2) | 1 (0.8) | 4 (2.4) | 3 (2.1) |
| CKD stage, N (%) | ||||
| 3 | 85 (45.7) | 20 (16.0)*** | 79 (47.6) | 26 (17.9)*** |
| 4 | 82 (44.1) | 65 (52.0) | 77 (46.4) | 70 (48.3) |
| 5 | 19 (10.2) | 40 (32.0) | 10 (6.0) | 49 (33.8) |
| Laboratory variables, Mean (SD) | ||||
| Serum hemoglobin, g/dL | 12.7 ± 1.53 | 10.6 ± 1.66*** | 12.4 ± 1.71 | 11.2 ± 1.90*** |
| Serum phosphorous, mg/dL | 3.7 ± 0.74 | 4.3 ± 1.18*** | 3.7 ± 0.46 | 4.3 ± 1.24*** |
| Adjusted calcium, mg/dL | 9.2 ± 0.44 | 8.8 ± 0.56** | 9.2 ± 0.36 | 8.8 ± 0.60*** |
| Medication use, Mean (SD) | ||||
| Types of medication | 7.4 ± 2.96 | 9.8 ± 3.23*** | 7.2 ± 3.00 | 9.7 ± 3.10*** |
| Daily pill burden | 11.1 ± 5.92 | 15.9 ± 6.81*** | 10.8 ± 5.68 | 15.5 ± 6.92*** |
CKD Chronic Kidney Disease
Results are expressed as mean ± standard deviation or number (%)
Statistical significance: **p < 0.01, ***p < 0.001